Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome-Reference-Cited by-同舟云学术

Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome

Published:2024-07-05 Issue:7 Volume:316 Page:
ISSN:1432-069X
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Lukowiak Tess M.^ORCID,Cahn Brian,Samie Faramarz,Leffell David J.,Oro Anthony,Kibbi Nour,Kheterpal Meenal,Babakoohi Shahab,Khushalani Nikhil I.,Stephenson Alice,Ma Melissa Sayaphupha,Shi Victoria J.,Ahmed Areeba,Koza Eric,Haq Misha,Yi Michael D.,Nadir Umer,Yoo Simon,Brieva Joaquin C.,Lucas Jennifer,Haber Roger,Alam Murad

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00403-024-03157-z.pdf

Reference5 articles.

1. Gorlin RJ (2004) Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 6(6):530–539

2. Tang JY, Mackay-Wiggan JM, Aszterbaum M et al (2012) Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 366(23):2180–2188

3. Bordeaux J, Blitzblau R, Aasi SZ (2024) Basal cell skin Cancer, Version 3.2024, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw

4. Sekulic A, Migden MR, Lewis K et al (2015) Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 72(6):1021–1026e1028

5. Migden MR, Guminski A, Gutzmer R et al (2015) Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol 16(6):716–728

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral smoothened inhibitors for Gorlin syndrome: A clinical review;Journal of the American Academy of Dermatology;2024-06